SEC Sues Two for Insider Trading of Sequenom and Exact Sciences Shares

The SEC alleges the two individuals traded shares of the two firms after receiving insider information about Sequenom's unsuccessful bid to acquire Exact Sciences in 2009 and Sequenom's mishandling of data on its Down syndrome test.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.